Legionella Infections

Total Page:16

File Type:pdf, Size:1020Kb

Legionella Infections Molecular detection and typing of Legionella infections Sophie JARRAUD ESCMID eLibrary © by author Disclosure Research Grants, consulting: Diagenode, IDEEX, bioMerieux, Orgentec, Alere ESCMID eLibrary © by author Legionella Legionnaires’ disease (LD) infections Pontiac fever = ü atypical pneumonia (eg. legionellosis ü a mild, flu-like disease extrapulmonary findings) ü without pneumonia ü severe pneumonia ü high attack rate ü Mortality: 10-30% ü short incubation period ü rapid recoveries Extrapulmonary forms ü with or without pneumonia ü especially due to L. non pneumophila ESCMIDü endocarditis, eLibrary arthritis … © by author Legionella associated to LD genus Legionella ~ 25 species: at least once isolated from humans L. pneumophila ~ 91% L. longbeachae ~ 5% cases worldwide ~ 60 L. micdadei ~ 2% species (with isolates available) Other species ~ 2% (Yu et al., J. infect. Dis. 2002) Legionella longbeachae : ~ 30% - 50% of the cases in Australia and New Zealand L. pneumophila is clearly predominant in human infection followed ESCMIDby L.eLibrary longbeachae © by author Legionella associated to LD Legionella pneumophila : ~ 91% of the cases worldwide (Yu et al., J. infect. Dis. 186:127-128) 16 L. pneumophila sg1: ~ 88,6% of cases serogroups ~ 30% of isolates from environment Higher virulence or better niche adaptation of ESCMIDLegionella eLibrary pneumophila Sg 1? © by author What is the use of Legionella PCR in Europe? Beauté J. et al. Legionnaires’ disease in Europe, 2011 to 2015. Eurosurveillance 2017 33,809 laboratory tests 29 reporting countries PCR, 6,8% other tests culture, (serology), 10,8% 1,1% Proportion of cases diagnosed by PCR increased 4.3% (2011) to 10.5% (2015) urinary antigen, ESCMID eLibrary78,2% © by author What are major advantages of Legionella PCR ? 1- main advantage: diagnosis of all Legionella spp. infections – largely unknown and suspected to be under-diagnosed – Legionella sp.: 16S rRNA, 5S rRNA, intergenic spacer region 23S-5S, • Species identification available after sequencing – L. pneumophila: mip gene (or other) ü L. non-pneumophila associated to immunocompromised patients ü Higher mortality due to these patients ESCMID eLibrary © by author 2- qPCR as a pronostic marker? q In respiratory samples Maurin et al., CMI, 2010 (n = 70); Murdoch et al., CID, 2013 (n = 114) • Correlation of bacterial load on admission with • Pneumonia severity index (Fine class or CURB-65) • Need for hospitalization in ICU • Duration of hospitalization • Mortality q limitation: standardization sampling procedure q Sputum and tracheal aspirate provide better results than Bronchial aspirate samples • higher positive rates ESCMID• higher bacterial loads eLibrary © by author 2- qPCR as a pronostic marker? q In respiratory samples Maurin et al., CMI, 2010 (n = 70); Murdoch et al., CID, 2013 (n = 114) • Correlation of bacterial load on admission with • Pneumonia severity index (Fine class or CURB-65) • Need for hospitalization in ICU • Duration of hospitalization • Mortality q In blood samples Lindsay et al., 1994; Murdoch et al., 1996; Murdoch et al., 1999; Murdoch et al., 2000; Matsiota-Bernard et al., 2000; Diederen et al., 2007; Van de Veerdonk et al. 2009; Mentasti et al., 2012 • ESCMIDCorrelation between PCR on serum eLibrary / LD severity not clear-cut © by author 3- Molecular method for detecting antibiotic resistance • resistance to antibiotics seems not a major problem for LD – Only 2 descriptions of resistance to Quinolone ! • 1 isolate from patient (Bruin et al. JAC 2014) • 1 description by targeted NGS (Shadoud et al. EBIOM 2015) – No description (from patient / environment) for macrolides and Rifampicin • Isolates available for only 12% of cases (diagnosed in Europe) • Development of molecular methods to confirm these data and to perform surveillance ESCMID eLibrary © by author 3- Molecular method for detecting antibiotic resistance • Molecular mechanisms associated to resistance determined on in vitro selected resistant mutants (Nielsen et al., 2000; Almahmoud et al., 2009; Descours et al., 2017) PCR and real time PCR assay Digital PCR Targeted sanger sequencing targeting mutations NGS method Resistant Quantification FQ resistance WT 1:1,000 resistant/ susceptible allele ratios Almahmoud et al., 2009 Hennebique et al., 2017 Shadoud et al. 2015 ESCMIDShadoud et al. 2015 eLibrary © by author Targeted Next Generation Sequencing (NGS) ü ability to detect minority subpopulations ü demonstration of in vivo selection of FQ-resistant mutants of Legionella for 2 patients during hospitalisation Shadoud et al. EBIOM (2015) Day of sampling % of gyrA83 mutant (D0= diagnosis) alleles Patient #2 D0 2.9 % D4 94 % Patient #4 D0 1.05 % D3 75 % D5 95 % % ESCMIDof mutated alleles in respiratory sampleseLibrary from control patients: <0.5% © by author 4- Rapid point of care diagnostic tests for viral and bacterial respiratory tract infections Why does Legionella a good candidate as target ? ü Severe pneumonia: rapid diagnosis ü Several mimics of LD: rapid differential diagnosis ü Potential co-infection: influenza virus / others ? ü Urinary antigen tests detect only Lp1 ESCMID eLibrary © by author ePlex® BIOFIRE® FILMARRAY® Respiratory Pathogen Pneumonia Panel (GenMark Diagnostics) (bioMéreux) Upper respiratory infection Lower respiratory infection Panels available for Legionella pneumophila DiaCORE® Unyvero® HPN Respiratory Panel (Curetis) (STAT Dx) Hospitalized pneumonia ESCMID eLibrary © by author ePlex® nasopharyngeal swabs not adapted to LD Respiratory Pathogen (GenMark Diagnostics) Upper respiratory infection CE-IVD cleared for nasopharyngeal swabs only R. H. T. Nijhuis, J Clin Microbiol. 2017 Analysed 6 LD from sputum = positive result DiaCORE® Respiratory Panel (STAT Dx) nasopharyngeal swabs ESCMIDNo publication eLibrary © by author Authorization seeked from the FDA BIOFIRE® FILMARRAY® Pneumonia Panel ü Sputum - endotracheal aspirate (bioMéreux) ü Bronchoalveolar Lavage ü No publication Lower respiratory infection ü Poster at ECCMID: only few LD tested Unyvero® HPN ü No publication (Curetis) ü Poster at ECCMID: only few LD tested Hospitalized pneumonia ü Incidence of LD is low ü We need also evaluation from National Centers ESCMIDof Legionella eLibrary © by author 5- 16S rRNA targeted metagenomic on clinical samples Which applications for Legionella infections? • Diversity of bacteria in clinical samples from LD – What are the dynamics of the lung microbiome and the pathogen during Legionella infection and antibiotic treatment? – Are there other bacteria needed to treat? • Legionella species identification – Are there several Legionella species in the clinical sample? ESCMIDLung microbiome during LDeLibrary - only very few published studies © by author What are the dynamics of the lung microbiome and the pathogen during Legionella infection and antibiotic treatment? Ana Elena PEREZ COBAS Carmen Buchrieser’s team Christophe Christophe Ginevra Rusniok ESCMID eLibrary © by author Persistent Legionella infection during hospitalisation Thoracic CT scan: chest X-ray a voluminous lung abscess Resection of abscess rapid clinical improvement D4 D5 D14 D24 D33 D42 D54 D62 D72 Erythromycin + Erythromycin + nitroimidazole Levofloxacin levofloxacin + levoflo + imidazole + Rifampicin (3 months) ESCMIDBAL: Legionella positive culture eLibrary © by author METHODS Illumina technology PCR 16S rRNA V3-V4 ITS1 Operational taxonomic units Bioinformatics algorythms ESCMID eLibraryAdapted from Hong et al , 2016 Clin. Microb. Rev. © by author RESULTS 16S rRNA sequencing Antibiotics 100 Actinobacteria Actinomyces Actinobacteria Atopobium Legionella Actinobacteria Corynebacterium Bacteroidetes Alloprevotella Bacteroidetes Prevotella 80 Firmicutes Abiotrophia Firmicutes Enterococcus Firmicutes Gemella Firmicutes Granulicatella Firmicutes Oribacterium Firmicutes Peptostreptococcus 60 Firmicutes Shuttleworthia Firmicutes Staphylococcus Firmicutes Streptococcus Firmicutes Veillonella Firmicutes uc_Lachnospiraceae Fusobacteria Fusobacterium 40 Proteobacteria Haemophilus Proteobacteria Legionella Tenericutes Mycoplasma Others 20 Very high abundance of Legionella in the microbiome during infection (75%) 0 Antibiotic therapy changes the diversity of the microbiome due to resistant species day 5 BAL day day 24 BAL 24 day 33 BAL day BAL 42 day day 14 BAL 14 day day 4 sputum4 day (Prevotella, Alloprevotella, Fusobacterium) ESCMID abscess 42 day eLibrary © by author RESULTS 16S rRNA sequencing 100 Actinobacteria Actinomyces Actinobacteria Atopobium Bacteroidetes Alloprevotella Sputum versus BAL Bacteroidetes Prevotella Firmicutes Abiotrophia High-abundance taxa > 2% (%) 80 Firmicutes Gemella Firmicutes Granulicatella Firmicutes Peptostreptococcus Firmicutes Streptococcus Firmicutes Veillonella Sputum Proteobacteria Legionella 60 Others Streptococcus (43%) abondance Prevotella (13%) Legionella Gemella (13%) 40 Legionella (3%) Relative 20 BAL Legionella (99%) 0 Highly different microbiome composition of BAL and sputum day 5 BAL 5 day sample ESCMIDsputum4 day eLibrary © by author RESULTS 16S rRNA sequencing 100 Actinobacteria Actinomyces Actinobacteria Atopobium Sputum versus BAL Actinobacteria Corynebacterium Actinobacteria Microbacterium Actinobacteria Propionibacterium Low-abundance taxa < 2% Actinobacteria uc_Actinomycetales (%) Bacteroidetes Alloprevotella 80 Bacteroidetes Flavobacterium Bacteroidetes Prevotella Crenarchaeota uc_Thermoprotei Cyanobacteria uc_Cyanobacteria Firmicutes Abiotrophia Firmicutes Atopostipes Firmicutes Enterococcus Firmicutes Exiguobacterium
Recommended publications
  • Legionnaires' Disease, Pontiac Fever, Legionellosis and Legionella
    Legionnaires’ Disease, Pontiac Fever, Legionellosis and Legionella Q: What is Legionellosis and who is at risk? Legionellosis is an infection caused by Legionella bacteria. Legionellosis can present as two distinct illnesses: Pontiac fever (a self-limited flu-like mild respiratory illness), and Legionnaires’ Disease (a more severe illness involving pneumonia). People of any age can get Legionellosis, but the disease occurs most frequently in persons over 50 years of age. The disease most often affects those who smoke heavily, have chronic lung disease, or have underlying medical conditions that lower their immune system, such as diabetes, cancer, or renal dysfunction. Persons taking certain drugs that lower their immune system, such as steroids, have an increased risk of being affected by Legionellosis. Many people may be infected with Legionella bacteria without developing any symptoms, and others may be treated without having to be hospitalized. Q: What is Legionella? Legionella bacteria are found naturally in freshwater environments such as creeks, ponds and lakes, as well as manmade structures such as plumbing systems and cooling towers. Legionella can multiply in warm water (77°F to 113°F). Legionella pneumophila is responsible for over 90 percent of Legionnaires’ Disease cases and several different species of Legionella are responsible for Pontiac Fever. Q: How is Legionella spread and how does someone acquire Legionellosis (Legionnaires’ Disease/Pontiac Fever)? Legionella bacteria become a health concern when they grow and spread in manmade structures such as plumbing systems, hot water tanks, cooling towers, hot tubs, decorative fountains, showers and faucets. Legionellosis is acquired after inhaling mists from a contaminated water source containing Legionella bacteria.
    [Show full text]
  • NCTC) Bacterial Strain Equivalents to American Type Culture Collection (ATCC) Bacterial Strains
    This list shows National Collection of Type Cultures (NCTC) bacterial strain equivalents to American Type Culture Collection (ATCC) bacterial strains. NCTC Number CurrentName ATCC Number NCTC 7212 Acetobacter pasteurianus ATCC 23761 NCTC 10138 Acholeplasma axanthum ATCC 25176 NCTC 10171 Acholeplasma equifetale ATCC 29724 NCTC 10128 Acholeplasma granularum ATCC 19168 NCTC 10172 Acholeplasma hippikon ATCC 29725 NCTC 10116 Acholeplasma laidlawii ATCC 23206 NCTC 10134 Acholeplasma modicum ATCC 29102 NCTC 10188 Acholeplasma morum ATCC 33211 NCTC 10150 Acholeplasma oculi ATCC 27350 NCTC 10198 Acholeplasma parvum ATCC 29892 NCTC 8582 Achromobacter denitrificans ATCC 15173 NCTC 10309 Achromobacter metalcaligenes ATCC 17910 NCTC 10807 Achromobacter xylosoxidans subsp. xylosoxidans ATCC 27061 NCTC 10808 Achromobacter xylosoxidans subsp. xylosoxidans ATCC 17062 NCTC 10809 Achromobacter xylosoxidans subsp. xylosoxidans ATCC 27063 NCTC 12156 Acinetobacter baumannii ATCC 19606 NCTC 10303 Acinetobacter baumannii ATCC 17904 NCTC 7844 Acinetobacter calcoaceticus ATCC 15308 NCTC 12983 Acinetobacter calcoaceticus ATCC 23055 NCTC 8102 acinetobacter dna group 13 ATCC 17903 NCTC 10304 Acinetobacter genospecies 13 ATCC 17905 NCTC 10306 Acinetobacter haemolyticus ATCC 17907 NCTC 10305 Acinetobacter haemolyticus subsp haemolyticus ATCC 17906 NCTC 10308 Acinetobacter johnsonii ATCC 17909 NCTC 10307 Acinetobacter junii ATCC 17908 NCTC 5866 Acinetobacter lwoffii ATCC 15309 NCTC 12870 Actinobacillus delphinicola ATCC 700179 NCTC 8529 Actinobacillus equuli ATCC 19392
    [Show full text]
  • Legionella Shows a Diverse Secondary Metabolism Dependent on a Broad Spectrum Sfp-Type Phosphopantetheinyl Transferase
    Legionella shows a diverse secondary metabolism dependent on a broad spectrum Sfp-type phosphopantetheinyl transferase Nicholas J. Tobias1, Tilman Ahrendt1, Ursula Schell2, Melissa Miltenberger1, Hubert Hilbi2,3 and Helge B. Bode1,4 1 Fachbereich Biowissenschaften, Merck Stiftungsprofessur fu¨r Molekulare Biotechnologie, Goethe Universita¨t, Frankfurt am Main, Germany 2 Max von Pettenkofer Institute, Ludwig-Maximilians-Universita¨tMu¨nchen, Munich, Germany 3 Institute of Medical Microbiology, University of Zu¨rich, Zu¨rich, Switzerland 4 Buchmann Institute for Molecular Life Sciences, Goethe Universita¨t, Frankfurt am Main, Germany ABSTRACT Several members of the genus Legionella cause Legionnaires’ disease, a potentially debilitating form of pneumonia. Studies frequently focus on the abundant number of virulence factors present in this genus. However, what is often overlooked is the role of secondary metabolites from Legionella. Following whole genome sequencing, we assembled and annotated the Legionella parisiensis DSM 19216 genome. Together with 14 other members of the Legionella, we performed comparative genomics and analysed the secondary metabolite potential of each strain. We found that Legionella contains a huge variety of biosynthetic gene clusters (BGCs) that are potentially making a significant number of novel natural products with undefined function. Surprisingly, only a single Sfp-like phosphopantetheinyl transferase is found in all Legionella strains analyzed that might be responsible for the activation of all carrier proteins in primary (fatty acid biosynthesis) and secondary metabolism (polyketide and non-ribosomal peptide synthesis). Using conserved active site motifs, we predict Submitted 29 June 2016 some novel compounds that are probably involved in cell-cell communication, Accepted 25 October 2016 Published 24 November 2016 differing to known communication systems.
    [Show full text]
  • Burkholderia Cenocepacia Intracellular Activation of the Pyrin
    Activation of the Pyrin Inflammasome by Intracellular Burkholderia cenocepacia Mikhail A. Gavrilin, Dalia H. A. Abdelaziz, Mahmoud Mostafa, Basant A. Abdulrahman, Jaykumar Grandhi, This information is current as Anwari Akhter, Arwa Abu Khweek, Daniel F. Aubert, of September 29, 2021. Miguel A. Valvano, Mark D. Wewers and Amal O. Amer J Immunol 2012; 188:3469-3477; Prepublished online 24 February 2012; doi: 10.4049/jimmunol.1102272 Downloaded from http://www.jimmunol.org/content/188/7/3469 Supplementary http://www.jimmunol.org/content/suppl/2012/02/24/jimmunol.110227 Material 2.DC1 http://www.jimmunol.org/ References This article cites 71 articles, 17 of which you can access for free at: http://www.jimmunol.org/content/188/7/3469.full#ref-list-1 Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision by guest on September 29, 2021 • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2012 by The American Association of Immunologists, Inc. All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. The Journal of Immunology Activation of the Pyrin Inflammasome by Intracellular Burkholderia cenocepacia Mikhail A.
    [Show full text]
  • Management Weaknesses Delayed Response to Flint Water Crisis
    U.S. ENVIRONMENTAL PROTECTION AGENCY OFFICE OF INSPECTOR GENERAL Ensuring clean and safe water Compliance with the law Management Weaknesses Delayed Response to Flint Water Crisis Report No. 18-P-0221 July 19, 2018 Report Contributors: Stacey Banks Charles Brunton Kathlene Butler Allison Dutton Tiffine Johnson-Davis Fred Light Jayne Lilienfeld-Jones Tim Roach Luke Stolz Danielle Tesch Khadija Walker Abbreviations CCT Corrosion Control Treatment CFR Code of Federal Regulations EPA U.S. Environmental Protection Agency FY Fiscal Year GAO U.S. Government Accountability Office LCR Lead and Copper Rule MDEQ Michigan Department of Environmental Quality OECA Office of Enforcement and Compliance Assurance OIG Office of Inspector General OW Office of Water ppb parts per billion PQL Practical Quantitation Limit PWSS Public Water System Supervision SDWA Safe Drinking Water Act Cover Photo: EPA Region 5 emergency response vehicle in Flint, Michigan. (EPA photo) Are you aware of fraud, waste or abuse in an EPA Office of Inspector General EPA program? 1200 Pennsylvania Avenue, NW (2410T) Washington, DC 20460 EPA Inspector General Hotline (202) 566-2391 1200 Pennsylvania Avenue, NW (2431T) www.epa.gov/oig Washington, DC 20460 (888) 546-8740 (202) 566-2599 (fax) [email protected] Subscribe to our Email Updates Follow us on Twitter @EPAoig Learn more about our OIG Hotline. Send us your Project Suggestions U.S. Environmental Protection Agency 18-P-0221 Office of Inspector General July 19, 2018 At a Glance Why We Did This Project Management Weaknesses
    [Show full text]
  • The Risk to Human Health from Free-Living Amoebae Interaction with Legionella in Drinking and Recycled Water Systems
    THE RISK TO HUMAN HEALTH FROM FREE-LIVING AMOEBAE INTERACTION WITH LEGIONELLA IN DRINKING AND RECYCLED WATER SYSTEMS Dissertation submitted by JACQUELINE MARIE THOMAS BACHELOR OF SCIENCE (HONOURS) AND BACHELOR OF ARTS, UNSW In partial fulfillment of the requirements for the award of DOCTOR OF PHILOSOPHY in ENVIRONMENTAL ENGINEERING SCHOOL OF CIVIL AND ENVIRONMENTAL ENGINEERING FACULTY OF ENGINEERING MAY 2012 SUPERVISORS Professor Nicholas Ashbolt Office of Research and Development United States Environmental Protection Agency Cincinnati, Ohio USA and School of Civil and Environmental Engineering Faculty of Engineering The University of New South Wales Sydney, Australia Professor Richard Stuetz School of Civil and Environmental Engineering Faculty of Engineering The University of New South Wales Sydney, Australia Doctor Torsten Thomas School of Biotechnology and Biomolecular Sciences Faculty of Science The University of New South Wales Sydney, Australia ORIGINALITY STATEMENT '1 hereby declare that this submission is my own work and to the best of my knowledge it contains no materials previously published or written by another person, or substantial proportions of material which have been accepted for the award of any other degree or diploma at UNSW or any other educational institution, except where due acknowledgement is made in the thesis. Any contribution made to the research by others, with whom 1 have worked at UNSW or elsewhere, is explicitly acknowledged in the thesis. I also declare that the intellectual content of this thesis is the product of my own work, except to the extent that assistance from others in the project's design and conception or in style, presentation and linguistic expression is acknowledged.' Signed ~ ............................
    [Show full text]
  • Multiple Legionella Pneumophila Effector Virulence Phenotypes
    Multiple Legionella pneumophila effector virulence PNAS PLUS phenotypes revealed through high-throughput analysis of targeted mutant libraries Stephanie R. Shamesa,1, Luying Liua, James C. Haveya, Whitman B. Schofielda,b, Andrew L. Goodmana,b, and Craig R. Roya,2 aDepartment of Microbial Pathogenesis, Yale University School of Medicine, New Haven, CT 06519; and bMicrobial Sciences Institute, Yale University School of Medicine, New Haven, CT 06519 Edited by Ralph R. Isberg, Howard Hughes Medical Institute/Tufts University School of Medicine, Boston, MA, and approved October 20, 2017 (received for review May 23, 2017) Legionella pneumophila is the causative agent of a severe pneu- poorly understood. Initial forward genetic screens aimed at identi- monia called Legionnaires’ disease. A single strain of L. pneumo- fying avirulent mutants of L. pneumophila were successful in identi- phila encodes a repertoire of over 300 different effector proteins fying essential components of the Dot/Icm system, but these screens that are delivered into host cells by the Dot/Icm type IV secretion did not identify effector proteins translocated by the Dot/Icm system system during infection. The large number of L. pneumophila ef- (10, 11). It is appreciated that most effectors are not essential for fectors has been a limiting factor in assessing the importance of intracellular replication (12), which is why the genes encoding ef- individual effectors for virulence. Here, a transposon insertion se- fector proteins that are important for virulence were difficult to quencing technology called INSeq was used to analyze replication identify by standard screening strategies that assess intracellular of a pool of effector mutants in parallel both in a mouse model of replication using binary assays that measure plaque formation or infection and in cultured host cells.
    [Show full text]
  • Host-Adaptation in Legionellales Is 2.4 Ga, Coincident with Eukaryogenesis
    bioRxiv preprint doi: https://doi.org/10.1101/852004; this version posted February 27, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC 4.0 International license. 1 Host-adaptation in Legionellales is 2.4 Ga, 2 coincident with eukaryogenesis 3 4 5 Eric Hugoson1,2, Tea Ammunét1 †, and Lionel Guy1* 6 7 1 Department of Medical Biochemistry and Microbiology, Science for Life Laboratories, 8 Uppsala University, Box 582, 75123 Uppsala, Sweden 9 2 Department of Microbial Population Biology, Max Planck Institute for Evolutionary 10 Biology, D-24306 Plön, Germany 11 † current address: Medical Bioinformatics Centre, Turku Bioscience, University of Turku, 12 Tykistökatu 6A, 20520 Turku, Finland 13 * corresponding author 14 1 bioRxiv preprint doi: https://doi.org/10.1101/852004; this version posted February 27, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC 4.0 International license. 15 Abstract 16 Bacteria adapting to living in a host cell caused the most salient events in the evolution of 17 eukaryotes, namely the seminal fusion with an archaeon 1, and the emergence of both the 18 mitochondrion and the chloroplast 2. A bacterial clade that may hold the key to understanding 19 these events is the deep-branching gammaproteobacterial order Legionellales – containing 20 among others Coxiella and Legionella – of which all known members grow inside eukaryotic 21 cells 3.
    [Show full text]
  • Legionella Pneumophila Lifecycle Critical Review Part I Uptake Into Host Cells
    water Review Knowledge to Predict Pathogens: Legionella pneumophila Lifecycle Critical Review Part I Uptake into Host Cells Alexis L. Mraz 1 and Mark H. Weir 1,2,* 1 Division of Environmental Health Sciences, College of Public Health, The Ohio State University, Columbus, OH 43210, USA; [email protected] 2 Risk Modeling Division, Applied Research Center, NSF International, Ann Arbor, MI 48105, USA * Correspondence: [email protected]; Tel.: +1-614-292-4066 Received: 16 December 2017; Accepted: 29 January 2018; Published: 31 January 2018 Abstract: Legionella pneumophila (L. pneumophila) is an infectious disease agent of increasing concern due to its ability to cause Legionnaires’ Disease, a severe community pneumonia, and the difficulty in controlling it within water systems. L. pneumophila thrives within the biofilm of premise plumbing systems, utilizing protozoan hosts for protection from disinfectants and other environmental stressors. While there is a great deal of information regarding how L. pneumophila interacts with protozoa and human macrophages (host for human infection), the ability to use this data in a model to attempt to predict a concentration of L. pneumophila in a water system is not known. The lifecycle of L. pneumophila within host cells involves three processes: uptake, growth, and egression from the host cell. The complexity of these three processes would risk conflation of the concepts; therefore, this review details the available information regarding how L. pneumophila invades host cells (uptake) within the context of data needed to model this process, while a second review will focus on growth and egression. The overall intent of both reviews is to detail how the steps in L.
    [Show full text]
  • Genetic and Functional Studies of the Mip Protein of Legionella
    t1.ì. Genetic and Functional Studies of the Mip Protein of Legionella Rodney Mark Ratcliff, BSc (Hons)' MASM Infectious Diseases Laboratories Institute of Medical and Veterinary Science and Department of Microbiology and Immunology UniversitY of Adelaide. Adelaide, South Australia A thesis submitted to the University of Adelaide for the degree of I)octor of Philosophy 15'h March 2000 amended 14th June 2000 Colonies of several Legionella strains on charcoal yeast extract agar (CYE) after 4 days incubation at 37"C in air. Various magnifications show typical ground-glass opalescent appearance. Some pure strains exhibit pleomorphic growth or colour. The top two photographs demonstrate typical red (LH) and blue-white (RH) fluorescence exhibited by some species when illuminated by a Woods (IJV) Lamp. * t Table of Contents .1 Chapter One: Introduction .1 Background .............'. .2 Morphology and TaxonomY J Legionellosis ............. 5 Mode of transmission "..'....'. 7 Environmental habitat 8 Interactions between Legionella and phagocytic hosts 9 Attachment 11 Engulfment and internalisation.'.. 13 Intracellular processing 13 Intracellular replication of legionellae .. " "' " "' 15 Host cell death and bacterial release 18 Virulence (the Genetic factors involved with intracellular multiplication and host cell killing .20 icm/dot system) Legiolysin .25 Msp (Znn* metaloprotease) ...'..... .25 .28 Lipopolysaccharide .29 The association of flagella with disease.. .30 Type IV fimbriae.... .31 Major outer membrane proteins....'.......'. JJ Heat shock proteins'.'. .34 Macrophage infectivity potentiator (Mip) protein Virulenceiraits of Legionella species other than L. pneumophila..........' .39 phylogeny .41 Chapter One (continued): Introduction to bacterial classification and .41 Identificati on of Legionella...'.,..'.. .46 Phylogeny .52 Methods of phylogenetic analysis' .53 Parsimony methods.'.. .55 Distance methods UPGMA cluster analYsis.'.'...
    [Show full text]
  • Electronic Laboratory Reporting Use Case January 2011
    ILLINOIS HEALTH INFORMATION EXCHANGE Electronic Laboratory Reporting Use Case Electronic Laboratory Reporting and Health Information Exchange Illinois Health Information Exchange Public Health Work Group January 2011 Electronic Laboratory Reporting Use Case January 2011 Table of Contents 1.0 Executive Summary……………………………………………………………………….3 2.0 Introduction…………………………………………………………………...……………..5 3.0 Scope……………………………………..………………………………………………………5 4.0 Use Case Stakeholders…………………………………………………………….….....6 5.0 Issues and Obstacles……………………………………………………………………...8 6.0 Use Case Pre-Conditions .………………….…………………………………………...8 7.0 Use Case Post-Conditions.……………………………………………………………...9 8.0 Detailed Scenarios/Technical Specifications.………………………………10 9.0 Validation and Certification………………………………………………………...12 Appendix ………………………………………………………………………………………….....13 Page 2 Electronic Laboratory Reporting Use Case January 2011 1.0 Executive Summary This Use Case is a product of the Public Health Work Group (PHWG) of the Illinois Health Information Exchange (HIE) Advisory Committee. The Illinois HIE Advisory Committee was constituted as the diverse public healthcare stakeholder body providing input and recommendations on the creation of the Illinois Health Information Exchange Authority (“the Authority”) as the Illinois vehicle for designing and implementing electronic health information exchange in Illinois. The establishment of the Authority marks the formal transition of the work of the HIE Advisory Committee and the Work Groups into alignment with the provisions of Illinois
    [Show full text]
  • Legionella Information for Community Public Water Systems, Health Care
    Legionella Information FOR COMMUNITY PUBLIC WATER SYSTEMS (CPWSs), HEALTH CARE FACILITIES, AND ALL TYPES OF BUILDINGS What is Legionella? Legionella is a bacterium commonly found in natural and man-made aquatic environments. Legionella can be found at low concentrations in any public water system. Legionella only poses a health risk when growth occurs in warm stagnant water, the water is aerosolized, and the small droplets are inhaled. Legionella generally does not pose a health risk if a person drinks the water. Those that are infected may develop legionellosis, a type of pneumonia called Legionnaires’ disease, or a flu-like illness called Pontiac fever. There has been an increase in Legionnaires’ disease cases nationwide and in Minnesota, with 17 confirmed cases in 2004 and 115 cases in 2016. The risk to people depends on many factors, including: 1. Amplification or growth of Legionella. ▪ Conditions such as water temperatures between 77oF and 108oF, stagnation, and the presence of scale, sediment, biofilm, and protozoa promote amplification of Legionella. 2. Aerosolization of colonized water. ▪ Common modes of aerosolization include showers and faucets, cooling towers, hot tubs, and decorative fountains and water features. 3. Size of the water droplets. 4. Strain of Legionella. 5. Susceptibility of exposed individual. ▪ Those who are over 50 years of age, are male, smoke, have chronic lung disease, and/or are immunocompromised or immunosuppressed are more susceptible. According to the Centers for Disease Control and Prevention (CDC), about 5,000 cases of Legionnaires’ disease are reported each year in the United States, and one out of every 10 people who get Legionnaires’ disease will die.
    [Show full text]